Kura Oncology KURA Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's other income (expense)?
- Kura Oncology (KURA) reported other income (expense) of $5.49M in Q1 2026.
- How has Kura Oncology's other income (expense) changed year-over-year?
- Kura Oncology's other income (expense) decreased by 26.8% year-over-year, from $7.5M to $5.49M.
- What is the long-term trend for Kura Oncology's other income (expense)?
- Over 4 years (2021 to 2025), Kura Oncology's other income (expense) has grown at a 137.6% compound annual growth rate (CAGR), from $792K to $25.26M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.